BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6276 related articles for article (PubMed ID: 3089671)

  • 1. Monoclonal antibodies produced against murine tyrosinase identify pigmented human melanocytes.
    Tomita Y; Hearing VJ
    Diagn Immunol; 1986; 4(3):149-54. PubMed ID: 3089671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-T4-tyrosinase monoclonal antibodies--specific markers for pigmented melanocytes.
    Tomita Y; Montague PM; Hearing VJ
    J Invest Dermatol; 1985 Nov; 85(5):426-30. PubMed ID: 2414367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine.
    Kwon BS; Halaban R; Kim GS; Usack L; Pomerantz S; Haq AK
    Mol Biol Med; 1987 Dec; 4(6):339-55. PubMed ID: 2449595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.
    McEwan M; Parsons PG; Moss DJ
    J Invest Dermatol; 1988 Apr; 90(4):515-9. PubMed ID: 3127479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
    Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
    Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
    Kageshita T; Ono T; Arao T; Tomita Y
    Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase.
    Riley JP; Rosenberg SA; Parkhurst MR
    J Immunother; 2001; 24(3):212-20. PubMed ID: 11394498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.
    Bouchard B; Fuller BB; Vijayasaradhi S; Houghton AN
    J Exp Med; 1989 Jun; 169(6):2029-42. PubMed ID: 2499655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme-linked immunoadsorbent assay and by immunotitration analysis.
    Fuller BB; Iman DS; Lunsford JB
    J Cell Physiol; 1988 Jan; 134(1):149-54. PubMed ID: 3121644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAT-1, a monoclonal antibody that specifically recognizes human tyrosinase.
    Takimoto H; Suzuki S; Masui S; Shibata K; Tomita Y; Shibahara S; Nakano H
    J Invest Dermatol; 1995 Dec; 105(6):764-8. PubMed ID: 7490469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilizing effect of Trition X-100 on melanosome tyrosinase in hamster pigmented melanoma.
    Blagoeva PM
    Neoplasma; 1977; 24(3):291-4. PubMed ID: 408715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive tyrosinase method for human skin.
    Wittbjer A; Odh G; Rosengren E; Rorsman H
    Acta Derm Venereol; 1991; 71(5):399-402. PubMed ID: 1684467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
    Imokawa G; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
    [No Abstract]   [Full Text] [Related]  

  • 14. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
    Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
    Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis.
    Willers J; Lucchese A; Mittelman A; Dummer R; Kanduc D
    Exp Dermatol; 2005 Jul; 14(7):543-50. PubMed ID: 15946243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
    Jungbluth AA; Iversen K; Coplan K; Kolb D; Stockert E; Chen YT; Old LJ; Busam K
    Pathol Res Pract; 2000; 196(4):235-42. PubMed ID: 10782467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
    Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
    Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA.
    Adema GJ; de Boer AJ; van 't Hullenaar R; Denijn M; Ruiter DJ; Vogel AM; Figdor CG
    Am J Pathol; 1993 Dec; 143(6):1579-85. PubMed ID: 7504884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
    Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 314.